Analysis

The Chinese electric-vehicle maker XPeng has kicked off sales of its flagship X9 van across Europe, but the premium model's...

SpaceX’s $20 Billion Bond Plan and $401 Analyst Target Collide as First Week Rally Fades

The initial frenzy around SpaceX's public listing has cooled sharply. After two straight days of losses, the stock slid more...

BayWa’s Revenue Plunges 34% as Legal Probes Mount and Creditors Circle Ahead of Autumn Deadline

BayWa’s first-quarter revenue collapsed 34% to €2.3 billion, deepening the crisis for the embattled German agribusiness group as it juggles...

D-Wave’s Advantage2 Usage Surges 314% as New Simulator and $100 Million CHIPS Grant Draw Closer

Two powerful catalysts are converging at D-Wave Quantum. The company is rolling out a novel error-revealing simulator in September, while...

Bayer’s All-or-Nothing Summer: A Supreme Court Ruling and a $7.25bn Settlement Duel

Two legal milestones are converging on Bayer within weeks, and the market is holding its breath. By the end of...

German Courts Tighten Employer Liability for Faulty Documentation — From Wage Claims to Email Delivery

That warning comes from a series of recent rulings spanning wage claims, internal investigations, overtime disputes, and email delivery —...

XPeng Faces Twin Pressures as Shareholder Vote Looms and Subsidies Fall Flat

The clock is ticking in two directions for XPeng. The electric-vehicle maker’s stock is hovering just a hair above its...

Outlook Therapeutics Nears FDA Verdict on July 29 After Record Rally and Steep Correction

The countdown has begun for Outlook Therapeutics, with the U.S. Food and Drug Administration setting a binding decision date of...

Fiserv Grapples with Dual Turmoil as New CEO Steps In Amidst Debt Restructuring

The payments processor Fiserv is facing a pivotal moment, with a change at the top coming at the same time...

SpaceX’s Post-IPO Correction Collides With a $338 Billion Analyst Gap